Literature DB >> 1544943

Inhibition of transcription of HIV-1 in infected human cells by oligodeoxynucleotides designed to form DNA triple helices.

W M McShan1, R D Rossen, A H Laughter, J Trial, D J Kessler, J G Zendegui, M E Hogan, F M Orson.   

Abstract

The effect on human immunodeficiency virus 1 (HIV-1) viral transcription and subsequent gene expression mediated by mixed purine-pyrimidine oligodeoxyribonucleotides (oligodeoxynucleotides) designed to form collinear DNA triplexes with purine-rich elements in the viral promoter was evaluated in intact mammalian cell lines (MT4 and U937). Oligonucleotides HIV31 (5'-GTTTTTGGGTGTTGTGGGTGTGTGTGGTTTG-3') and HIV38 (5'-TGGGTGGGGTGGGGTGGGGGGGTGTGGGGTGTGGGGTG-3') were designed to interact with the transcription initiation site (-16 to + 13) and nuclear factor Sp1 binding site (-81 to -44) of HIV-1, respectively. Oligonucleotides, synthesized with a 3' amine blocking group (5'-R-O-PO2-OCH (CHOH)-CH2-NH+3-3') to prevent degradation by cellular nucleases, were readily taken up by MT4 cells from the culture medium, achieving measured intranuclear concentrations higher than the medium in less than 2 h of incubation. The 3' amine modified oligonucleotides were recoverable from the cells after 24 h as greater than 90% intact material. Treatment of acutely infected MT4 cells with either HIV31 or HIV38 significantly inhibited viral-associated cytopathology and P24 antigen production (p less than 0.001). Additionally, inhibition of P24 antigen release, culture supernatant viral titer, and expression of the intact 9.2-kb HIV-1 mRNA was observed when the chronically infected promonocyte cell line, U937, was treated with 10 microM HIV38. Control oligonucleotides with similar base composition did not inhibit virus expression in either cell line. Furthermore, inhibition of viral expression was not due to alpha-interferon induction resulting from oligonucleotide treatment. Both HIV31 and HIV38 associate with their respective DNA target duplexes at micromolar concentrations, and a strong negative ellipticity near 210 nm, characteristic of DNA triplexes, was observed in the circular dichroism spectrum of either target-oligonucleotide complex. These observations suggest that oligonucleotides, designed to form nucleic acid triplexes with specific proviral target sequences, can selectively inhibit transcription of viral mRNA in intact cells and suppress accumulation of viral products.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544943

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Triplex forming oligonucleotide targeted to 3'UTR downregulates the expression of the bcl-2 proto-oncogene in HeLa cells.

Authors:  C Shen; A Buck; G Mehrke; B Polat; H Gross; M Bachem; S Reske
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

2.  Molecular recognition via triplex formation of mixed purine/pyrimidine DNA sequences using oligoTRIPs.

Authors:  Jian-Sen Li; Fa-Xian Chen; Ronald Shikiya; Luis A Marky; Barry Gold
Journal:  J Am Chem Soc       Date:  2005-09-14       Impact factor: 15.419

3.  Detection and kinetic studies of triplex formation by oligodeoxynucleotides using real-time biomolecular interaction analysis (BIA).

Authors:  P J Bates; H S Dosanjh; S Kumar; T C Jenkins; C A Laughton; S Neidle
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

4.  Cleavage of double-stranded DNA by 'metalloporphyrin-linker-oligonucleotide' molecules: influence of the linker.

Authors:  P Bigey; G Pratviel; B Meunier
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

5.  Effect of competing self-structure on triplex formation with purine-rich oligodeoxynucleotides containing GA repeats.

Authors:  S B Noonberg; J C François; T Garestier; C Hélène
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

6.  Detection of covalent triplex within human cells.

Authors:  A L Guieysse; D Praseuth; M Grigoriev; A Harel-Bellan; C Hélène
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

7.  Polyamine effects on purine-purine-pyrimidine triple helix formation by phosphodiester and phosphorothioate oligodeoxyribonucleotides.

Authors:  M Musso; M W Van Dyke
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

8.  Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.

Authors:  J Wang; C Jones; M Norcross; E Bohnlein; A Razzaque
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 9.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

10.  Effect of abasic linker substitution on triplex formation, Sp1 binding, and specificity in an oligonucleotide targeted to the human Ha-ras promoter.

Authors:  C Mayfield; D Miller
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.